NeoCore Technology Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	no data
Proprietà del CEO	n/a
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	Nessun dato

Aggiornamenti recenti sulla gestione

Recent updates

DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of Debt

Apr 19

DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of Debt

Jan 04

AMMINISTRATORE DELEGATO

NeoCore Technology non ha un CEO, o non abbiamo dati su di loro.

NeoCore Technology Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024

DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021

Recent updates

Third quarter 2024 earnings released: NT$0.36 loss per share (vs NT$0.50 loss in 3Q 2023)

Second quarter 2024 earnings released: NT$0.39 loss per share (vs NT$0.39 loss in 2Q 2023)

New minor risk - Share price stability

First quarter 2024 earnings released: NT$0.40 loss per share (vs NT$0.45 loss in 1Q 2023)

NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: NT$1.87 loss per share (vs NT$1.49 loss in FY 2022)

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$0.39 loss per share (vs NT$0.52 loss in 2Q 2022)

Full year 2022 earnings released: NT$1.49 loss per share (vs NT$0.91 loss in FY 2021)

Third quarter 2022 earnings released: NT$0.44 loss per share (vs NT$0.23 loss in 3Q 2021)

Second quarter 2022 earnings released: NT$0.52 loss per share (vs NT$0.19 loss in 2Q 2021)

First quarter 2022 earnings released: NT$0.21 loss per share (vs NT$0.13 loss in 1Q 2021)

Third quarter 2021 earnings released: NT$0.09 loss per share (vs NT$0.097 loss in 3Q 2020)

Second quarter 2021 earnings released: NT$0.08 loss per share (vs NT$0.12 loss in 2Q 2020)

First quarter 2021 earnings released: NT$0.05 loss per share (vs NT$0.20 loss in 1Q 2020)

DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of Debt

Full year 2020 earnings released: NT$0.56 loss per share (vs NT$0.25 loss in FY 2019)

DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021

New 90-day high: NT$7.65

New 90-day low: NT$5.15

New 90-day low: NT$6.13

DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of Debt

New 90-day low: NT$7.00

New 90-day low: NT$7.27

Third quarter 2020 earnings released: NT$0.09 loss per share

New 90-day low: NT$7.80

New 90-day low: NT$7.87

First half earnings released

AMMINISTRATORE DELEGATO